Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study
NCT05598775 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 9
Last updated 2023-03-31
Summary
The purpose of this long-term safety study is to follow up subjects treated with CTX0E03 DP to monitor for delayed oncological, neurological, and CTX0E03 DP-related adverse events and to monitor survival
Conditions
Interventions
- OTHER
-
Non Interventional long term safety follow up
Non Interventional long term safety follow up
Sponsors & Collaborators
-
ReNeuron Limited
lead INDUSTRY
Principal Investigators
-
Amy Miller, RPh, PharmD · UBC
Eligibility
- Min Age
- 35 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-01
- Primary Completion
- 2026-11-01
- Completion
- 2026-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Tenecteplase in Stroke Patients Between 4.5 and 24 Hours
NCT03785678 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke
NCT00815763 ·Status: COMPLETED ·Phase: PHASE3
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）
NCT05745259 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
NCT02059785 ·Status: SUSPENDED ·Phase: PHASE2
-
Mild and Rapidly Improving Stroke Study
NCT02072681 ·Status: COMPLETED
-
HT-3951 vs. Placebo in Stroke Rehabilitation
NCT02530307 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 ·Status: COMPLETED ·Phase: PHASE2
-
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)
NCT05965687 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT05515393 ·Status: UNKNOWN ·Phase: PHASE2
-
A Proof of Concept Study to Evaluate CN-105 in ICH Patients
NCT03168581 ·Status: COMPLETED ·Phase: PHASE2
-
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial
NCT05172934 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke
NCT01518231 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
NCT05445895 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Safety and Effectiveness of the Penumbra System
NCT00334061 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
NCT04091945 ·Status: COMPLETED ·Phase: PHASE2
-
Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
NCT06785740 ·Status: RECRUITING
-
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
NCT01208233 ·Status: TERMINATED ·Phase: PHASE2
-
Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
NCT07279259 ·Status: RECRUITING ·Phase: PHASE2
-
A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
NCT03766581 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT06755944 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III
NCT05141305 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
NCT00790920 ·Status: COMPLETED ·Phase: PHASE3
-
Non-immunogenic Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
NCT05697575 ·Status: RECRUITING